$3.2 Billion is the total value of Redmile Group, LLC's 70 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 9.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | $502,351,000 | -33.7% | 12,957,222 | 0.0% | 15.68% | -9.0% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $211,459,000 | -19.4% | 22,329,386 | -1.7% | 6.60% | +10.7% |
| ARGX | Sell | ARGENX SEsponsored adr | $162,682,000 | -10.9% | 515,943 | -1.1% | 5.08% | +22.3% |
| LIVN | Sell | LIVANOVA PLC | $161,247,000 | -10.3% | 1,970,511 | -4.2% | 5.03% | +23.1% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $120,817,000 | -5.1% | 1,815,698 | -0.3% | 3.77% | +30.2% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $110,668,000 | -32.6% | 2,615,030 | +1.1% | 3.46% | -7.5% |
| ADCT | Sell | ADC THERAPEUTICS SA | $109,182,000 | -27.5% | 7,432,429 | -0.2% | 3.41% | -0.4% |
| SCIENCE 37 HOLDINGS INC | $105,974,000 | -57.1% | 19,808,234 | 0.0% | 3.31% | -41.1% | ||
| BEAM | Sell | BEAM THERAPEUTICS INC | $105,206,000 | -30.0% | 1,836,050 | -2.6% | 3.28% | -3.9% |
| SKIN | Buy | THE BEAUTY HEALTH COMPANY | $89,540,000 | -27.1% | 5,304,505 | +4.4% | 2.80% | +0.1% |
| IGMS | IGM BIOSCIENCES INC | $89,127,000 | -8.9% | 3,334,355 | 0.0% | 2.78% | +25.1% | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $69,696,000 | -16.7% | 2,046,269 | -5.5% | 2.18% | +14.4% |
| ABSCI CORPORATION | $67,702,000 | +2.8% | 8,031,094 | 0.0% | 2.11% | +41.1% | ||
| RGNX | Buy | REGENXBIO INC | $65,614,000 | +5.8% | 1,976,923 | +4.2% | 2.05% | +45.2% |
| SGEN | Buy | SEAGEN INC | $63,566,000 | +10.6% | 441,274 | +18.7% | 1.98% | +51.8% |
| REPL | Sell | REPLIMUNE GROUP INC | $62,678,000 | -40.2% | 3,691,312 | -4.5% | 1.96% | -17.8% |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $58,025,000 | -42.8% | 6,245,911 | -3.0% | 1.81% | -21.5% |
| CNC | Buy | CENTENE CORP DEL | $54,626,000 | +83.6% | 648,837 | +79.7% | 1.70% | +151.8% |
| IMGN | Buy | IMMUNOGEN INC | $43,877,000 | -28.4% | 9,217,945 | +11.6% | 1.37% | -1.7% |
| STOK | Sell | STOKE THERAPEUTICS INC | $42,613,000 | -20.9% | 2,024,368 | -9.9% | 1.33% | +8.6% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $42,293,000 | -50.6% | 3,018,784 | +2.0% | 1.32% | -32.2% |
| AUGX | AUGMEDIX INC | $42,278,000 | -6.7% | 14,380,327 | 0.0% | 1.32% | +28.2% | |
| VERV | Buy | VERVE THERAPEUTICS INC | $41,882,000 | -33.5% | 1,835,328 | +7.4% | 1.31% | -8.7% |
| ANTM | Sell | ANTHEM INC | $40,851,000 | -20.1% | 83,162 | -24.6% | 1.28% | +9.7% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $38,918,000 | -33.8% | 2,732,996 | -2.0% | 1.22% | -9.1% |
| ONEM | New | 1LIFE HEALTHCARE INC | $37,726,000 | – | 3,404,835 | +100.0% | 1.18% | – |
| OSH | OAK STR HEALTH INC | $32,353,000 | -18.9% | 1,203,619 | 0.0% | 1.01% | +11.4% | |
| TNDM | New | TANDEM DIABETES CARE INC | $31,540,000 | – | 271,218 | +100.0% | 0.98% | – |
| Sell | SOMALOGIC INC | $31,332,000 | -35.0% | 3,906,770 | -5.7% | 0.98% | -10.8% | |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $31,030,000 | -49.0% | 2,407,326 | -1.7% | 0.97% | -29.9% |
| NVTA | INVITAE CORP | $30,329,000 | -47.8% | 3,805,403 | 0.0% | 0.95% | -28.3% | |
| NVRO | Buy | NEVRO CORP | $29,729,000 | +35.8% | 411,017 | +52.2% | 0.93% | +86.3% |
| GRTS | Buy | GRITSTONE BIO INC | $28,312,000 | -35.8% | 6,871,738 | +100.4% | 0.88% | -11.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $27,255,000 | -48.1% | 53,445 | -48.9% | 0.85% | -28.7% |
| PRTA | Sell | PROTHENA CORP PLC | $26,922,000 | -28.8% | 736,175 | -3.9% | 0.84% | -2.3% |
| ISEE | Sell | IVERIC BIO INC | $25,006,000 | -0.3% | 1,485,800 | -0.9% | 0.78% | +37.0% |
| STTK | SHATTUCK LABS INC | $23,941,000 | -49.9% | 5,619,914 | 0.0% | 0.75% | -31.3% | |
| Sell | STEVANATO GROUP S P A | $23,143,000 | -11.9% | 1,150,225 | -1.7% | 0.72% | +20.9% | |
| AKRO | AKERO THERAPEUTICS INC | $22,736,000 | -32.9% | 1,602,285 | 0.0% | 0.71% | -7.8% | |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $21,596,000 | -48.1% | 3,080,801 | -0.1% | 0.67% | -28.8% |
| ICUI | Sell | ICU MED INC | $21,567,000 | -58.7% | 96,869 | -56.0% | 0.67% | -43.3% |
| Sell | ENTRADA THERAPEUTICS INC | $18,352,000 | -45.2% | 1,954,419 | -0.0% | 0.57% | -24.7% | |
| BVS | Sell | BIOVENTUS INC | $18,284,000 | -4.8% | 1,296,739 | -2.1% | 0.57% | +30.7% |
| NUVB | Sell | NUVATION BIO INC | $18,261,000 | -41.5% | 3,471,709 | -5.4% | 0.57% | -19.6% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $17,865,000 | +43.0% | 114,764 | +17.0% | 0.56% | +96.5% |
| Sell | THE ONCOLOGY INSTITUTE INC | $17,215,000 | -29.4% | 2,414,432 | -3.4% | 0.54% | -3.1% | |
| RAPT | New | RAPT THERAPEUTICS INC | $16,463,000 | – | 748,677 | +100.0% | 0.51% | – |
| ALLK | Buy | ALLAKOS INC | $14,592,000 | -28.3% | 2,559,975 | +23.2% | 0.46% | -1.3% |
| ZYME | Buy | ZYMEWORKS INC | $13,848,000 | -3.4% | 2,114,197 | +141.8% | 0.43% | +32.5% |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $13,054,000 | -22.3% | 772,397 | -1.2% | 0.41% | +6.5% |
| LVTX | LAVA THERAPEUTICS NV | $12,391,000 | -20.0% | 2,816,196 | 0.0% | 0.39% | +9.9% | |
| MDVL | MEDAVAIL HOLDINGS INC | $10,755,000 | -30.6% | 11,075,105 | 0.0% | 0.34% | -4.5% | |
| HOOK | Buy | HOOKIPA PHARMA INC | $10,572,000 | +90.2% | 4,636,648 | +94.4% | 0.33% | +161.9% |
| ANNX | Sell | ANNEXON INC | $8,744,000 | -76.4% | 3,202,917 | -0.8% | 0.27% | -67.6% |
| ADAGIO THERAPEUTICS INC | $8,760,000 | -37.2% | 1,920,960 | 0.0% | 0.27% | -13.9% | ||
| TKNO | Sell | ALPHA TEKNOVA INC | $7,841,000 | -47.2% | 567,800 | -21.7% | 0.24% | -27.5% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $6,515,000 | -61.3% | 3,465,435 | -0.7% | 0.20% | -47.0% |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $6,163,000 | -5.1% | 664,817 | 0.0% | 0.19% | +29.7% | |
| IMTX | Sell | IMMATICS N.V | $5,793,000 | -75.6% | 725,000 | -58.9% | 0.18% | -66.5% |
| ALVR | ALLOVIR INC | $5,558,000 | -47.8% | 823,371 | 0.0% | 0.17% | -28.5% | |
| STXS | Sell | STEREOTAXIS INC | $5,548,000 | -47.3% | 1,487,495 | -12.4% | 0.17% | -27.6% |
| ACHL | Sell | ACHILLES THERAPEUTICS PLCsponsored ads | $4,728,000 | -54.8% | 1,608,089 | -23.0% | 0.15% | -37.8% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $3,021,000 | -51.8% | 1,094,645 | -18.7% | 0.09% | -34.3% |
| XERIS BIOPHARMA HOLDINGS INC | $2,679,000 | -12.6% | 1,046,587 | 0.0% | 0.08% | +20.0% | ||
| BCEL | ATRECA INC | $2,537,000 | +4.6% | 800,306 | 0.0% | 0.08% | +43.6% | |
| SONENDO INC | $1,998,000 | -30.4% | 498,131 | 0.0% | 0.06% | -4.6% | ||
| AYLA | Sell | AYALA PHARMACEUTICALS INC | $1,790,000 | -68.5% | 449,731 | -32.7% | 0.06% | -56.6% |
| CABA | CABALETTA BIO INC | $1,414,000 | -46.4% | 696,377 | 0.0% | 0.04% | -26.7% | |
| CTSO | Sell | CYTOSORBENTS CORP | $850,000 | -71.7% | 266,365 | -62.9% | 0.03% | -60.3% |
| EPZM | EPIZYME INC | $523,000 | -54.0% | 454,475 | 0.0% | 0.02% | -38.5% | |
| RCEL | Exit | AVITA MEDICAL INC | $0 | – | -672,411 | -100.0% | -0.18% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -582,805 | -100.0% | -0.24% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -998,114 | -100.0% | -0.37% | – |
| GMAB | Exit | GENMAB A/Ssponsored ads | $0 | – | -661,621 | -100.0% | -0.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.